A prediction model for predicting relapsed-free survival of early-stage invasive breast cancer patients with hormone receptor positive based on Ki67, HER2 and TOP2A
Chemotherapy, TOP2A, HER2, and Ki67 expression were independent predictors of RFS in early-stage IBC patients with HR<sup>+</sup>. The nomogram we developed using these predictors is a reliable tool for predicting RFS in this patient population.
Authors
- Dawei Yuan (ORCID: https://orcid.org/0000-0002-1318-764X)
- Haixia Ye
- Wenbo Liu (ORCID: https://orcid.org/0000-0003-2560-0777)
- Rulan Ma
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.3389/fonc.2025.1552937
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00